BERGSTEIN IVAN (Chief Executive Officer) sold 2.2% of their position (56.03K shares) of STEMLINE THERAPEUTICS INC on the open market
Open‑market sale worth $607.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 1/3/2020ACC: 0001104659-20-000978
DirectorOfficer· Chief Executive Officer
Since Sep 2018
-56.03K
Net shares
Net seller
$607.3K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
56.03K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−5.22K
Price / share
$10.58
Trade value
$55.28K
% of position
0.2%
12/23/2019
2.57M→2.57M
Common Stock
Direct
Shares
−29.61K
Price / share
$10.97
Trade value
$324.85K
% of position
1.2%
12/24/2019
2.57M→2.54M
Common Stock
Direct
Shares
−18.74K
Price / share
$10.75
Trade value
$201.50K
% of position
0.7%
12/26/2019
2.54M→2.52M
Common Stock
Direct
Shares
−2.45K
Price / share
$10.48
Trade value
$25.63K
% of position
0.1%
12/27/2019
2.52M→2.51M
Total
Net shares
−56.03K
Net value
-$607.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/23/2019 | S · Sale | −5.22K | $10.58 | $55.28K | 0.2% | 2.57M | 2.57M |
| Common Stock Direct | 12/24/2019 | S · Sale | −29.61K | $10.97 | $324.85K | 1.2% | 2.57M | 2.54M |
| Common Stock Direct | 12/26/2019 | S · Sale | −18.74K | $10.75 | $201.50K | 0.7% | 2.54M | 2.52M |
| Common Stock Direct | 12/27/2019 | S · Sale | −2.45K | $10.48 | $25.63K | 0.1% | 2.52M | 2.51M |
| Total | −56.03K | -$607.27K | ||||||
Derivative Transactions0
No derivative transactions reported